Antidepressants in Parkinson's disease

A dataset of 11 trials comparing the effectiveness of five antidepressants and placebo in Parkinson's disease. The analysed binary outcome is the number of patients with a reduction of at least 50/ the baseline score.

Usage

data(nma.liu2013)

Format

A data frame with 11 rows of arm-based data and 13 columns (maximum number of 3 arms).

Source

Liu J, Dong J, Wang L, Yan P, Sun S. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis. PLoS One 2013;8(10):e76651. doi: 10.1371/journal.pone.0076651

Details

The interventions have been coded as follows: 1, placebo; 2, pramipexole; 3, serotonin-norepinephrine reuptake inhibitor; 4, selective serotonin reuptake inhibitor; 5, tricyclic antidepressant; and 6, pergolide.